AstraZeneca Canada Inc. is a prominent biopharmaceutical company specializing in the research, development, and manufacturing of innovative medicines. With a focus on areas such as oncology, cardiovascular, renal, and respiratory diseases, AstraZeneca aims to address significant unmet medical needs. The company leverages advanced technologies and scientific expertise to drive breakthroughs in drug development, contributing to improved patient outcomes. Headquartered in Mississauga, Canada, AstraZeneca plays a vital role in the global healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#57 in Mississauga

#1,069 in Canada

#42,290 in the World

Mississauga, Canada

Astrazeneca Canada Inc.

Forward Citations = 43

14 inventors:

Edward Roberts (10 out of 13 patents)

Daniel Delorme (6 out of 38 patents)

Philippe Walker (4 out of 8 patents)

4. Benjamin Pelcman (3 out of 27 patents)

5. Vlad Edward Gregor (3 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Astrazeneca Canada Inc.. Retrieved from https://idiyas.com/company/astrazeneca-canada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]